The Effects of Types of Fruits and Vegetables on Vascular Function
CIRCUS
2 other identifiers
interventional
36
1 country
2
Brief Summary
The CIRCUS study is a randomised controlled, cross-over trial to evaluate the effects of increased intakes of citrus fruits and cruciferous vegetables on vascular function in 36 untreated, prehypertensive participants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2017
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 4, 2017
CompletedFirst Submitted
Initial submission to the registry
December 3, 2017
CompletedFirst Posted
Study publicly available on registry
January 25, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 21, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 21, 2021
CompletedMarch 22, 2022
March 1, 2022
3.8 years
December 3, 2017
March 7, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Blood pressure
Changes in systolic and diastolic blood pressure (mmHg) measured by automated oscillometric device (average of 3 measurements).
Measured on the morning after each of three recurring run-in periods and after each of three recurring 2-week intervention periods, 6 times total during 9 weeks
Secondary Outcomes (10)
Arterial stiffness
Measured on the morning after each of three recurring run-in periods and after each of three recurring 2-week intervention periods, 6 times total during 9 weeks
Markers of cardiometabolic health measured in fasted blood samples
Measured on the morning after each of three recurring run-in periods and after each of three recurring 2-week intervention periods, 6 times total during 9 weeks
Markers of endothelial function measured in fasted blood samples
Measured on the morning after each of three recurring run-in periods and after each of three recurring 2-week intervention periods, 6 times total during 9 weeks
Markers of low-grade inflammation measured in fasted blood samples
Measured on the morning after each of three recurring run-in periods and after each of three recurring 2-week intervention periods, 6 times total during 9 weeks
Urinary metabolic profiles
Measured on the morning after each of three recurring run-in periods and after each of three recurring 2-week intervention periods, 6 times total during 9 weeks
- +5 more secondary outcomes
Study Arms (3)
Low Fruits and Vegetables (LFV)
PLACEBO COMPARATOR1 portion of fruits plus 1 portion of vegetables, of commonly consumed types per day. Intakes are at 25th percentile of UK consumption (NDNS) and will exclude citrus fruits, cruciferous and allium vegetables.
High Fruits and Vegetables (HFV)
EXPERIMENTAL4 portions of fruits plus 4 portions of vegetables, of commonly consumed types per day excluding citrus fruits, cruciferous and allium vegetables.
High Citrus fruits and Cruciferous vegetables (CC)
EXPERIMENTAL4 portions of citrus fruits plus 4 portions of cruciferous vegetables per day excluding any other types of fruits and vegetables including allium vegetables.
Interventions
1 apple/banana/small bunch of grapes per day plus 1 portion of carrot/pepper/tomato per day
4 portions of fruits (apples, bananas, grapes, pears) plus 4 portions of vegetables (carrots, cucumber, sweet peppers, tomatoes), of commonly consumed types per day excluding citrus fruits, cruciferous and allium vegetables.
4 portions of citrus fruits (clementines, grapefruits, lemons, oranges) plus 4 portions of cruciferous vegetables (broccoli, brussels sprouts, cauliflower, kale, savoy cabbage) per day.
Eligibility Criteria
You may qualify if:
- years
- Average systolic blood pressure of 125-140 mmHg at 2 measurements separated by \>30 minutes
- No use of antihypertensive medication
- No reported current or previous diabetes mellitus, (secondary) hypertension, or metabolic, cardiovascular, renal, liver, thyroid, gastrointestinal diseases
- Body Mass Index between 20 - 35 kg/m2
- Non-smoker
- Average fruit and vegetable consumption of \<4 portions per day (UK average, 40-65 years), or willing to reduce habitual daily fruit and vegetable intake.
You may not qualify if:
- Any medication likely to interfere with energy metabolism, appetite regulation and hormonal balance.
- Excessive alcohol intake of \> 21 units per week (females) or \>28 units per week (male) and not willing to limit alcohol intake to maximum of 1 unit/day
- Physical activity of \>=10 hours/week of moderate to vigorous physical activity
- Weight loss or gain of \>=3 kg in the preceding 3 months
- Use of dietary supplements or unwilling to stop supplement use \>= 2 weeks before enrolment and during intervention
- Pregnancy or lactation
- Intervention specific factors, including:
- Unable or unwilling to consume provided diets during the intervention
- Unsufficient storage space for provided diets
- Food sensitivities or vegetarian/vegan diet by choice
- Participation in another intervention study at the same time
- Living \> 15 miles from the Imperial/NIHR Clinical Research Facility at Hammersmith Hospital
- No signed informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Cambridgelead
- Imperial College Londoncollaborator
Study Sites (2)
Cambridge Epidemiology & Trials Unit
Cambridge, United Kingdom
Imperial/NIHR Clinical Research Facility
London, W12 0HS, United Kingdom
Study Officials
- PRINCIPAL INVESTIGATOR
Linda Oude Griep, PhD
MRC Epidemiology Unit, University of Cambridge
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Research Associate
Study Record Dates
First Submitted
December 3, 2017
First Posted
January 25, 2018
Study Start
September 4, 2017
Primary Completion
June 21, 2021
Study Completion
June 21, 2021
Last Updated
March 22, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- In a timely manner when results have been published in peer-reviewed journals.
As describe in study protocol